Back to Journals » OncoTargets and Therapy » Volume 12

Successful treatment with osimertinib and its subsequent resistance mechanism in a patient with non-small-cell lung cancer harboring acquired EGFR T790M mutation after recovery from AC0010-induced interstitial lung disease

Total article views   HTML views PDF downloads Totals
236,312 Dovepress* 235,673+ 902 236,575
PubMed Central* 639 145 784
Totals 236,312 1,047 237,359
*Since 10 July 2019

View citations on PubMed Central and Google Scholar